The new efforts come on top of ongoing fragment discovery and NMR-based structural biology services on target-ligand complexes ZoBio is already providing to J&JPRD.

GSK has elected to extend its collaboration with ZoBio to include fragment discovery on a new target as well as NMR-based structural biology on target-ligand complexes for an ongoing drug discovery campaign.

ZoBio is proud that such a high percentage of our customers come back for new projects and new services. This repeat business is a clear validation of our customer centric philosophy.